Zhimin Wang

Wenzhou Medical University - Taizhou First People's Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

91

TOTAL CITATIONS

3

Scholarly Papers (1)

1.

Sublingual Edaravone Dexborneol for the Treatment of Acute Ischemic Stroke (TASTE-SL): A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial

Number of pages: 34 Posted: 18 Aug 2023
Peking University - Department of Neurology, State Key Laboratory of Neurology and Oncology Drug Development, Capital Medical University - Department of Neurology, Capital Medical University - Beijing Tiantan Hospital, Capital Medical University - Department of Neurology, Capital Medical University - Department of Epidemiology, State Key Laboratory of Neurology and Oncology Drug Development, Neurodawn Pharmaceutical Co., Ltd, Neurodawn Pharmaceutical Co., Ltd, State Key Laboratory of Neurology and Oncology Drug Development, State Key Laboratory of Neurology and Oncology Drug Development, Neurodawn Pharmaceutical Co., Ltd, Harrison International Peace Hospital, Daqing Oilfields General Hospital, Nanshi Hospital of Nanyang, Pingxiang People's Hospital, Nanyang Medical College, Liaocheng People's Hospital, Shenyang Medical College, Mei He Kou Central Hospital, Hainan Medical University - Hainan General Hospital, Xuzhou Central Hospital, Cangzhou Central Hospital, Jilin University, Wenzhou Medical University - Taizhou First People's Hospital, Anhui Medical University - Department of Neurology, Baotou Medical College - Department of Neurology and Peking University - Department of Neurology
Downloads 91 (617,816)
Citation 3

Abstract:

Loading...

Acute ischemic stroke, Sublingual edaravone dexborneol, Brain cytoprotection agents, Randomized clinical trial